Efficacy of berberine in patients with type 2 diabetes mellitus

Metabolism - Tập 57 Số 5 - Trang 712-717 - 2008
Jun Yin1, Xing Hui-li1, Jianping Ye1
1Department of Endocrinology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Jayaprakasam, 2006, Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas), J Agric Food Chem, 54, 243, 10.1021/jf0520342

Matsui, 2001, Alpha-glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-glucosidase inhibition by isolated acylated anthocyanins, J Agric Food Chem, 49, 1952, 10.1021/jf0012502

Yin, 2002, Effects of berberine on glucose metabolism in vitro, Metabolism, 51, 1439, 10.1053/meta.2002.34715

Yin, 2004, Effects of berberine on glucose and lipid metabolism in animal experiment, Chin J Diabet, 12, 215

Lee, 2006, Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states, Diabetes, 55, 2256, 10.2337/db06-0006

Yin, 2008, Berberine improves glucose metabolism through induction of glycolysis, Am J Physiol Endocrinol Metab, 294, E148, 10.1152/ajpendo.00211.2007

Matthews, 1985, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, 28, 412, 10.1007/BF00280883

Ni YX. Therapeutic effect of berberine on 60 patients with type II diabetes mellitus and experimental research. Zhong Xi Yi Jie He Za Zhi 1988;8:711-3, 707

DeFronzo, 1995, Efficacy of metformin in patients with non–insulin-dependent diabetes mellitus, N Engl J Med, 333, 541, 10.1056/NEJM199508313330902

Ceriello, 2005, Comparison of effect of pioglitazone with metformin or sulfonylurea (monotherapy and combination therapy) on postload glycemia and composite insulin sensitivity index during an oral glucose tolerance test in patients with type 2 diabetes, Diabetes Care, 28, 266, 10.2337/diacare.28.2.266

Tang, 2006, Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats, J Ethnopharmacol, 108, 109, 10.1016/j.jep.2006.04.019

Zhou, 2007, Berberine stimulates glucose transport through a mechanism distinct from insulin, Metabolism, 56, 405, 10.1016/j.metabol.2006.10.025

Gao, 1997, Experimental study on berberin raised insulin sensitivity in insulin resistance rat models, Zhong Xi Yi Jie He Za Zhi, 17, 162

Ko, 2005, Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma, Biol Pharm Bull, 28, 1431, 10.1248/bpb.28.1431

Pan, 2003, Inhibitory action of berberine on glucose absorption, Yao Xue Xue Bao, 38, 911

Pan, 2003, The antihyperglycaemic activity of berberine arises from a decrease of glucose absorption, Planta Med, 69, 632, 10.1055/s-2003-41121

Kong, 2004, Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins, Nat Med, 10, 1344, 10.1038/nm1135

Leng, 2004, Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion, Acta Pharmacol Sin, 25, 496

Doggrell, 2005, Berberine—a novel approach to cholesterol lowering, Expert Opin Investig Drugs, 14, 683, 10.1517/13543784.14.5.683

Abidi, 2005, Extracellular signal–regulated kinase–dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine, Arterioscler Thromb Vasc Biol, 25, 2170, 10.1161/01.ATV.0000181761.16341.2b

Brusq, 2006, Inhibition of lipid synthesis through activation of AMP-kinase: an additional mechanism for the hypolipidemic effects of Berberine, J Lipid Res, 47, 1281, 10.1194/jlr.M600020-JLR200